SANJAY MATHEW to Placebos
This is a "connection" page, showing publications SANJAY MATHEW has written about Placebos.
Connection Strength
0.153
-
A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur Neuropsychopharmacol. 2011 Mar; 21(3):221-9.
Score: 0.081
-
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol. 2010 Feb; 13(1):71-82.
Score: 0.072